Evalueserve Interview Questions, Process, and Tips

Q1. What is Ev/ EBITDA ratio
Ans. 
Ev/ EBITDA ratio is a financial metric used to evaluate a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
• EV/EBITDA is calculated by dividing a company's enterprise value (EV) by its EBITDA.

• It is a popular valuation metric used to compare companies in the same industry.

• A lower EV/EBITDA ratio indicates that a company may be undervalued, while a higher ratio may suggest th...read more
Answered by AI
Add your answer

Q1. How does 3D glasses work?
Ans. 
3D glasses work by creating an illusion of depth perception by showing different images to each eye.
• 3D glasses use different colored lenses or polarizing filters to show different images to each eye

• The brain combines the two images to create a perception of depth

• Some 3D glasses use active shutter technology to alternate between showing images to each eye

• 3D glasses are commonly used in movies, video games, and virtual r
Answered by AI
Add your answer

Strategy formulation for a response to an OA

Q1. Expected renumeration
Add your answer

Round duration - 60 minutes
Round difficulty - Medium

On-Campus under the invigilation of College professors and campus placement ambassadors.

Q1. 
Count Subsequences Problem Statement
Given an integer array ARR of size N, your task is to find the total number of subsequences in which all elements are equal.
Explanation:
A subsequence of an array i...read more
Add your answer
Q2. 
Reverse Linked List Problem Statement
Given a singly linked list of integers, return the head of the reversed linked list.
Example:
Initial linked list: 1 -> 2 -> 3 -> 4 -> NULL
Reversed link...read more
Add your answer

Round duration - 30 minutes
Round difficulty - Medium

Q1. How would you automate the process of searching for profiles using a database of stored mobile numbers and email addresses?
Add your answer

Round duration - 20 minutes
Round difficulty - Easy

Clinical trial assessment and competitive asset profiling for specific diseases.

Same as first round, but drilled down significantly. Potential go-to-market strategy for high-profile assets.